(-)-epigallocatechin 3-gallate multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP3K1 mRNA CTD PMID:22079256 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of MAP3K1 protein CTD PMID:17337753 1-chloro-2,4-dinitrobenzene affects binding ISO MAP3K1 (Homo sapiens) 6480464 Dinitrochlorobenzene binds to MAP3K1 protein CTD PMID:32991956 17alpha-ethynylestradiol affects expression ISO Map3k1 (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of MAP3K1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of MAP3K1 mRNA CTD PMID:12655037 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of MAP3K1 mRNA CTD PMID:20170705 17beta-estradiol multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [Estradiol co-treated with IGF1R mutant form] results in increased expression of MAP3K1 mRNA CTD PMID:23094148 2,2',4,4',5,5'-hexachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:22889935 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Map3k1 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Map3k1 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Map3k1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of MAP3K1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of MAP3K1 mRNA CTD PMID:33387578 2,5-hexanedione increases expression EXP 6480464 2 and 5-hexanedione results in increased expression of MAP3K1 protein CTD PMID:31760062 2-methylcholine affects expression ISO MAP3K1 (Homo sapiens) 6480464 beta-methylcholine affects the expression of MAP3K1 mRNA CTD PMID:21179406 3-chloropropane-1,2-diol decreases expression EXP 6480464 alpha-Chlorohydrin results in decreased expression of MAP3K1 mRNA CTD PMID:28522335 4,4'-sulfonyldiphenol increases methylation ISO Map3k1 (Mus musculus) 6480464 bisphenol S results in increased methylation of MAP3K1 exon CTD PMID:33297965 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of MAP3K1 mRNA CTD PMID:21346803 5-fluorouracil affects expression ISO MAP3K1 (Homo sapiens) 6480464 Fluorouracil affects the expression of MAP3K1 mRNA CTD PMID:34151400 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of MAP3K1 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of MAP3K1 mRNA CTD PMID:31881176 acetazolamide increases expression ISO Map3k1 (Mus musculus) 6480464 Acetazolamide results in increased expression of MAP3K1 mRNA CTD PMID:19274763 alachlor increases expression EXP 6480464 alachlor results in increased expression of MAP3K1 mRNA CTD PMID:12419858 aldehydo-D-glucose increases expression ISO Map3k1 (Mus musculus) 6480464 Glucose results in increased expression of MAP3K1 mRNA CTD PMID:24659233 aldehydo-D-glucose multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 aldehydo-D-glucose multiple interactions ISO Map3k1 (Mus musculus) 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA] CTD PMID:24659233 all-trans-retinoic acid increases expression ISO MAP3K1 (Homo sapiens) 6480464 Tretinoin results in increased expression of MAP3K1 mRNA CTD PMID:23724009 all-trans-retinoic acid decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of MAP3K1 mRNA CTD PMID:33167477 allethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein CTD PMID:34896426 amino acid multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Amino Acids CTD PMID:27278863 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of MAP3K1 mRNA CTD PMID:16483693 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [[MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate] and pyrazolanthrone inhibits the reaction [MAP3K1 protein results in increased expression of ABCB1 mRNA] CTD PMID:15604272 and PMID:27278863 aristolochic acid A decreases expression ISO MAP3K1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of MAP3K1 mRNA CTD PMID:33212167 arsane affects methylation ISO MAP3K1 (Homo sapiens) 6480464 Arsenic affects the methylation of MAP3K1 gene CTD PMID:25304211 arsenic atom affects methylation ISO MAP3K1 (Homo sapiens) 6480464 Arsenic affects the methylation of MAP3K1 gene CTD PMID:25304211 benzo[a]pyrene increases expression ISO MAP3K1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of MAP3K1 protein CTD PMID:16041517 benzo[a]pyrene decreases methylation ISO Map3k1 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased methylation of MAP3K1 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO MAP3K1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased methylation of MAP3K1 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased expression of MAP3K1 protein] CTD PMID:16041517 benzo[a]pyrene diol epoxide I decreases expression ISO MAP3K1 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of MAP3K1 mRNA CTD PMID:16648578 bisphenol A affects expression ISO MAP3K1 (Homo sapiens) 6480464 bisphenol A affects the expression of MAP3K1 mRNA CTD PMID:20170705 bisphenol A multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [MAP3K1 protein co-treated with bisphenol A] results in decreased expression of APOA1 mRNA CTD PMID:31842455 bisphenol A decreases expression ISO Map3k1 (Mus musculus) 6480464 bisphenol A results in decreased expression of MAP3K1 mRNA CTD PMID:33221593 bisphenol A increases expression ISO MAP3K1 (Homo sapiens) 6480464 bisphenol A results in increased expression of MAP3K1 mRNA CTD PMID:29275510 and PMID:33670352 bisphenol A decreases methylation ISO Map3k1 (Mus musculus) 6480464 bisphenol A results in decreased methylation of MAP3K1 promoter CTD PMID:27312807 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of MAP3K1 mRNA CTD PMID:25181051 buta-1,3-diene decreases expression ISO Map3k1 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of MAP3K1 mRNA CTD PMID:29038090 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of MAP3K1 mRNA CTD PMID:19167457 cadmium dichloride increases expression ISO MAP3K1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of MAP3K1 mRNA CTD PMID:32512071 caffeine increases phosphorylation ISO MAP3K1 (Homo sapiens) 6480464 Caffeine results in increased phosphorylation of MAP3K1 protein CTD PMID:35688186 calcitriol increases expression ISO MAP3K1 (Homo sapiens) 6480464 Calcitriol results in increased expression of MAP3K1 mRNA CTD PMID:26485663 carbon nanotube decreases expression ISO Map3k1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube increases expression ISO Map3k1 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of MAP3K1 mRNA CTD PMID:25620056 carboplatin decreases expression EXP 6480464 Carboplatin results in decreased expression of MAP3K1 mRNA CTD PMID:18172885 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of MAP3K1 mRNA CTD PMID:18172885 CGP 52608 multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to MAP3K1 gene] CTD PMID:28238834 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of MAP3K1 mRNA CTD PMID:18172885 cisplatin increases expression ISO Map3k1 (Mus musculus) 6480464 Cisplatin results in increased expression of MAP3K1 mRNA CTD PMID:26546572 clozapine increases expression EXP 6480464 Clozapine results in increased expression of MAP3K1 mRNA CTD PMID:15860345 copper atom multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of MAP3K1 mRNA CTD PMID:30911355 copper(0) multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [Chelating Agents binds to Copper] which results in increased expression of MAP3K1 mRNA CTD PMID:30911355 copper(II) sulfate increases expression ISO MAP3K1 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of MAP3K1 mRNA CTD PMID:19549813 curcumin multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 Curcumin inhibits the reaction [MAP3K1 protein results in increased expression of IVL mRNA] and Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA] CTD PMID:17148446 and PMID:23452621 curcumin decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Curcumin results in decreased expression of MAP3K1 mRNA CTD PMID:15713895 cyclosporin A decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of MAP3K1 mRNA CTD PMID:20106945 cyhalothrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein CTD PMID:34896426 cypermethrin multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein CTD PMID:34896426 D-glucose multiple interactions ISO Map3k1 (Mus musculus) 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA] CTD PMID:24659233 D-glucose multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 D-glucose increases expression ISO Map3k1 (Mus musculus) 6480464 Glucose results in increased expression of MAP3K1 mRNA CTD PMID:24659233 dacarbazine decreases response to substance ISO MAP3K1 (Homo sapiens) 6480464 MAP3K1 protein modified form results in decreased susceptibility to Dacarbazine CTD PMID:15123733 dibutyl phthalate increases expression ISO Map3k1 (Mus musculus) 6480464 Dibutyl Phthalate results in increased expression of MAP3K1 mRNA CTD PMID:21266533 diclofenac increases expression ISO Map3k1 (Mus musculus) 6480464 Diclofenac results in increased expression of MAP3K1 mRNA CTD PMID:26934552 diethylstilbestrol increases expression ISO Map3k1 (Mus musculus) 6480464 Diethylstilbestrol results in increased expression of MAP3K1 mRNA CTD PMID:22467019 dioxygen multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 3 more ... CTD PMID:23452621 dioxygen increases expression ISO MAP3K1 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of MAP3K1 mRNA CTD PMID:23452621 doxorubicin decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of MAP3K1 mRNA CTD PMID:29803840 ellagic acid decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Ellagic Acid results in decreased expression of MAP3K1 mRNA and Ellagic Acid results in decreased expression of MAP3K1 protein CTD PMID:23811531 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of MAP3K1 mRNA CTD PMID:29391264 enniatin decreases expression EXP 6480464 enniatins results in decreased expression of MAP3K1 mRNA CTD PMID:27163883 epoxiconazole increases expression ISO Map3k1 (Mus musculus) 6480464 epoxiconazole results in increased expression of MAP3K1 mRNA CTD PMID:35436446 fenvalerate multiple interactions EXP 6480464 [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of MAP3K1 protein CTD PMID:34896426 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of MAP3K1 mRNA CTD PMID:24793618 formaldehyde decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of MAP3K1 mRNA CTD PMID:20655997 FR900359 affects phosphorylation ISO MAP3K1 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of MAP3K1 protein CTD PMID:37730182 furan increases methylation EXP 6480464 furan results in increased methylation of MAP3K1 gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of MAP3K1 mRNA CTD PMID:26194646 geldanamycin increases expression ISO MAP3K1 (Homo sapiens) 6480464 geldanamycin results in increased expression of MAP3K1 mRNA CTD PMID:26705709 genistein multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 Genistein inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA] CTD PMID:23452621 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of MAP3K1 mRNA CTD PMID:22061828 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of MAP3K1 mRNA CTD PMID:33387578 glucose increases expression ISO Map3k1 (Mus musculus) 6480464 Glucose results in increased expression of MAP3K1 mRNA CTD PMID:24659233 glucose multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Glucose CTD PMID:27278863 glucose multiple interactions ISO Map3k1 (Mus musculus) 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA] CTD PMID:24659233 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of MAP3K1 mRNA CTD PMID:15860345 heptachlor decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Heptachlor results in decreased expression of MAP3K1 protein CTD PMID:9704902 hexachlorobenzene affects expression EXP 6480464 Hexachlorobenzene affects the expression of MAP3K1 mRNA CTD PMID:15159207 hyaluronic acid multiple interactions ISO Map3k1 (Mus musculus) 6480464 Hyaluronic Acid analog affects the localization of [MAP3K1 protein binds to CD44 protein] more ... CTD PMID:20159036 iohexol increases expression ISO MAP3K1 (Homo sapiens) 6480464 Iohexol results in increased expression of MAP3K1 mRNA CTD PMID:29705293 iopamidol increases expression ISO MAP3K1 (Homo sapiens) 6480464 Iopamidol results in increased expression of MAP3K1 mRNA CTD PMID:29705293 lipopolysaccharide multiple interactions ISO Map3k1 (Mus musculus) 6480464 3 and 4-dihydroxybenzohydroxamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of MAP3K1 mRNA] CTD PMID:25843059 lipopolysaccharide increases expression ISO Map3k1 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of MAP3K1 mRNA CTD PMID:25843059 LY294002 multiple interactions ISO Map3k1 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased activity of MAP3K1 protein] CTD PMID:11306679 microcystin-LR increases expression ISO Map3k1 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of MAP3K1 mRNA CTD PMID:17654400 monosodium L-glutamate decreases expression EXP 6480464 Sodium Glutamate results in decreased expression of MAP3K1 mRNA CTD PMID:28954212 N-methyl-4-phenylpyridinium increases cleavage ISO MAP3K1 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased cleavage of MAP3K1 protein CTD PMID:10737593 nickel sulfate affects response to substance ISO Map3k1 (Mus musculus) 6480464 MAP3K1 protein affects the susceptibility to nickel sulfate CTD PMID:18467339 nickel sulfate decreases expression ISO MAP3K1 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of MAP3K1 mRNA CTD PMID:22714537 nickel sulfate multiple interactions ISO Map3k1 (Mus musculus) 6480464 [MAP3K1 protein co-treated with MAP3K2 protein] affects the susceptibility to nickel sulfate and MAP3K1 protein affects the reaction [nickel sulfate results in increased phosphorylation of MAPK8 protein] CTD PMID:18467339 o-anisidine decreases expression ISO MAP3K1 (Homo sapiens) 6480464 2-anisidine results in decreased expression of MAP3K1 mRNA CTD PMID:28089782 ochratoxin A decreases expression ISO MAP3K1 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of MAP3K1 mRNA CTD PMID:30763683 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MAP3K1 mRNA CTD PMID:25729387 ozone multiple interactions ISO Map3k1 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of MAP3K1 mRNA CTD PMID:34911549 p-menthan-3-ol increases expression ISO MAP3K1 (Homo sapiens) 6480464 Menthol results in increased expression of MAP3K1 mRNA CTD PMID:26760959 paclitaxel multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 aspartyl-glutamyl-valyl-aspartal inhibits the reaction [Paclitaxel results in increased cleavage of MAP3K1 protein] more ... CTD PMID:11160861 paclitaxel increases cleavage ISO MAP3K1 (Homo sapiens) 6480464 Paclitaxel results in increased cleavage of MAP3K1 protein CTD PMID:11160861 paclitaxel affects localization ISO MAP3K1 (Homo sapiens) 6480464 Paclitaxel affects the localization of MAP3K1 protein CTD PMID:11160861 paracetamol affects expression ISO Map3k1 (Mus musculus) 6480464 Acetaminophen affects the expression of MAP3K1 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of MAP3K1 mRNA CTD PMID:33387578 PCB138 multiple interactions ISO Map3k1 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of MAP3K1 mRNA CTD PMID:19162173 phenobarbital decreases expression ISO Map3k1 (Mus musculus) 6480464 Phenobarbital results in decreased expression of MAP3K1 mRNA CTD PMID:31836555 phenylephrine multiple interactions EXP 6480464 MEKK1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] CTD PMID:10727428 phorbol 13-acetate 12-myristate multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate more ... CTD PMID:27278863 potassium chromate multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MAP3K1 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO MAP3K1 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of MAP3K1 mRNA CTD PMID:22079256 pyrethrins decreases expression EXP 6480464 Pyrethrins results in decreased expression of MAP3K1 protein CTD PMID:34896426 quercetin increases expression ISO MAP3K1 (Homo sapiens) 6480464 Quercetin results in increased expression of MAP3K1 mRNA CTD PMID:23727915 quercetin increases phosphorylation ISO MAP3K1 (Homo sapiens) 6480464 Quercetin results in increased phosphorylation of MAP3K1 protein CTD PMID:35688186 resveratrol multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of MAP3K1 mRNA] CTD PMID:23452621 resveratrol multiple interactions ISO Map3k1 (Mus musculus) 6480464 resveratrol inhibits the reaction [Glucose results in increased expression of MAP3K1 mRNA] CTD PMID:24659233 SB 203580 multiple interactions ISO MAP3K1 (Homo sapiens) 6480464 SB 203580 inhibits the reaction [[MAP3K1 gene mutant form results in increased activity of MAP3K1 protein] which results in increased susceptibility to Tetradecanoylphorbol Acetate] CTD PMID:27278863 silver atom decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Silver analog results in decreased expression of MAP3K1 mRNA CTD PMID:24462830 silver atom decreases expression ISO Map3k1 (Mus musculus) 6480464 Silver results in decreased expression of MAP3K1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Silver analog results in decreased expression of MAP3K1 mRNA CTD PMID:24462830 silver(0) decreases expression ISO Map3k1 (Mus musculus) 6480464 Silver results in decreased expression of MAP3K1 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO MAP3K1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of MAP3K1 mRNA CTD PMID:22714537 sodium arsenite affects methylation ISO MAP3K1 (Homo sapiens) 6480464 sodium arsenite affects the methylation of MAP3K1 gene CTD PMID:28589171 sodium dichromate decreases expression ISO Map3k1 (Mus musculus) 6480464 sodium bichromate results in decreased expression of MAP3K1 mRNA CTD PMID:22155349 sodium dodecyl sulfate decreases expression EXP 6480464 Sodium Dodecyl Sulfate results in decreased expression of MAP3K1 mRNA CTD PMID:12815608 sodium fluoride decreases expression ISO Map3k1 (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of MAP3K1 mRNA CTD PMID:27862939 sulindac sulfide decreases expression ISO MAP3K1 (Homo sapiens) 6480464 sulindac sulfide results in decreased expression of MAP3K1 mRNA CTD PMID:12734198 tamoxifen affects expression ISO Map3k1 (Mus musculus) 6480464 Tamoxifen affects the expression of MAP3K1 mRNA CTD PMID:17555576 Tanshinone I decreases expression ISO MAP3K1 (Homo sapiens) 6480464 tanshinone results in decreased expression of MAP3K1 mRNA CTD PMID:15849732 temozolomide increases expression ISO MAP3K1 (Homo sapiens) 6480464 Temozolomide results in increased expression of MAP3K1 mRNA CTD PMID:31758290 testosterone increases expression ISO Map3k1 (Mus musculus) 6480464 Testosterone deficiency results in increased expression of MAP3K1 mRNA CTD PMID:33848595 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MAP3K1 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of MAP3K1 mRNA CTD PMID:23411599 and PMID:34492290 tipifarnib increases expression EXP 6480464 tipifarnib results in increased expression of MAP3K1 mRNA CTD PMID:16403772 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of MAP3K1 mRNA CTD PMID:25729387 tungsten decreases expression ISO Map3k1 (Mus musculus) 6480464 Tungsten results in decreased expression of MAP3K1 mRNA CTD PMID:30912803 undecane decreases expression EXP 6480464 undecane results in decreased expression of MAP3K1 protein CTD PMID:17337753 urethane multiple interactions ISO Map3k1 (Mus musculus) 6480464 [Urethane co-treated with Freund's Adjuvant] results in increased expression of MAP3K1 mRNA more ... CTD PMID:11062179 and PMID:12400877 urethane decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Urethane results in decreased expression of MAP3K1 mRNA CTD PMID:28818685 Urolithin A decreases expression ISO MAP3K1 (Homo sapiens) 6480464 3 more ... CTD PMID:23811531 valproic acid increases methylation ISO MAP3K1 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of MAP3K1 gene CTD PMID:29154799 valproic acid affects expression ISO MAP3K1 (Homo sapiens) 6480464 Valproic Acid affects the expression of MAP3K1 mRNA CTD PMID:25979313 valproic acid decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of MAP3K1 mRNA CTD PMID:23179753 and PMID:28001369 vincristine decreases expression ISO MAP3K1 (Homo sapiens) 6480464 Vincristine results in decreased expression of MAP3K1 mRNA CTD PMID:23649840 vitamin E multiple interactions ISO Map3k1 (Mus musculus) 6480464 Vitamin E inhibits the reaction [Urethane results in increased phosphorylation of and results in increased activity of MAP3K1 protein] CTD PMID:11062179 zinc atom decreases expression EXP 6480464 Zinc results in decreased expression of MAP3K1 mRNA CTD PMID:17074742 zinc dichloride multiple interactions ISO Map3k1 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [zinc chloride results in increased activity of MAP3K1 protein] and PIK3CG protein affects the reaction [zinc chloride results in increased activity of MAP3K1 protein] CTD PMID:11306679 zinc dichloride increases activity ISO Map3k1 (Mus musculus) 6480464 zinc chloride results in increased activity of MAP3K1 protein CTD PMID:11306679 zinc sulfate decreases expression EXP 6480464 Zinc Sulfate results in decreased expression of MAP3K1 mRNA CTD PMID:17074742 zinc(0) decreases expression EXP 6480464 Zinc results in decreased expression of MAP3K1 mRNA CTD PMID:17074742